Rhabdomyosarcoma Market Global Overview, Demand Analysis and Global Forecast to 2023
Market Highlights: Rhabdomyosarcoma is anticipated to grow at a CAGR of 4.8%. Rhabdomyosarcoma or RMS is a type of soft tissue cancer. It is rare cancer and affects the skeletal muscle tissue. Sometimes, it also affects the hollow organs like uterus or bladder. RMS can affect people of any age, but it mostly affects children. The increasing prevalence of rhabdomyosarcoma, rising research & development expenditure and useful molecules in the pipeline are expected to drive the growth of the market during the forecast period. Additionally, the increasing awareness among people is likely to boost the market growth. On the other hand, high treatment costs, side effects of the treatment, improper results of the drugs in the pipeline and strict government regulations may hinder the growth of the market during the forecast period. The global Rhabdomyosarcoma Market is currently dominated by many market players. The key players in the market are engaging themselves in new product ...